Clinical trials

Return to Life Return to Work research grants announced

Australia’s working age stroke survivors are set to benefit from research into innovative recovery and rehabilitation clinical interventions.

Stroke Foundation has announced the recipients of the $1 million ‘Return to life, return to work’ clinical research grants for 2019.

Funded by the Federal Government through the Medical Research Future Fund, the research package includes Australia’s first multicentred clinical trial of Perispinal Etanercept in chronic stroke.

Stroke Foundation Research Advisory Committee Chair Professor Amanda Thrift said the grants were an investment into the future of Australia’s younger stroke survivors.

Grant recipients:

Professor Vincent Thijs, The Florey Institute of Neuroscience and Mental Health

Perispinal Etanercept to improve Stroke Outcomes (PESTO)

Seeks to determine if Perispinal Etanercept improves quality of life in working age patients who have a history of stroke and moderate to severe disability. It will also investigate if repeated treatments lead to improved quality of life compared to one treatment.

Associate Professor Natasha Lannin, School of Allied Health, Latrobe University, Alfred Health

Does an embedded vocational rehabilitation intervention improve employment outcomes above and beyond standard stroke rehabilitation?

The grant will fund a pilot project to test the feasibility and potential benefit of building on current clinical rehabilitation by adding an embedded 12 week targeted vocational rehabilitation.


For any enquiries, please contact:

Stroke Foundation Compliance Officer, Michelle Adamson
Telephone: 03 9918 7215


Funding for this research has been provided by the Medical Research Future Fund (MRFF). The MRFF has been established by the Australian Government to provide grants of financial assistance to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians. MRFF funding has been provided to Stroke Foundation under the MRFF Accelerated Research Program announced as part the MRFF’s disbursement package in October 2018. Further information on the MRFF and disbursements are available at